A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation

Journal of Urology

Volumn 168, Issue 6, 2002, Pages 2486-2489

  Salonia, Andrea ^a   Maga, Tommaso ^a   Colombo, Renzo ^a   Scattoni, Vincenzo ^a   Briganti, Alberto ^a   Cestari, Andrea ^a   Guazzoni, Giorgio ^a   Rigatti, Patrizio ^a   Montorsi, Francesco ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Coitus; Ejaculation; Paroxetine; Penis; Questionnaires

Indexed keywords

PAROXETINE; SILDENAFIL;

ADULT; ARTICLE; CLINICAL TRIAL; COITUS; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EJACULATION; EJACULATION DISORDER; FLUSHING; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; LATENT PERIOD; LIBIDO; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NAUSEA; ORGASM; PREMATURE EJACULATION; PRIORITY JOURNAL; QUESTIONNAIRE; SATISFACTION; SEXUAL FUNCTION; SEXUAL INTERCOURSE; SIDE EFFECT;

EID: 0036895170     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)64174-2     Document Type: Article

References (23)

1. Read, S., King, M. and Watson, J.: Sexual dysfunction in primary medical care: Prevalence, characteristics and detection by the general practitioner. J Public Health Med, 19: 387, 1997
2. Laumann, E. O., Paik, A. and Rosen, R.: Sexual dysfunction in the United States: Prevalence and predictors. JAMA, 281: 537, 1999
3. Diagnostic and Statistical Manual of Mental Disorders, DSM-IV, 4th Ed. Washington, D. C.: Ameriban Psychiatric Association, p. 509, 1994
4. McMahon, C. G. and Touma, K.: Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 Single-blind placebo controlled crossover studies. J Urol, 161: 1826, 1999
5. Vale, J.: Ejaculatory dysfunction. BJU Int, 83: 557, 1999
6. Rosen, R. C., Lane, R. M. and Menza, M.: Effects of SSRIs on sexual function: A critical review. J Clin Psychopharmacol, 19: 67, 1999
7. Segraves, R. T.: Treatment-emergent sexual dysfunction in affective disorder: A review and management strategies. J Clin Psychiatr Monogr, 11: 57, 1993
8. Kara, H., Aydin, S., Aǧargün, M. Y., Odabaş, O. and Yilmaz, Y.: The efficacy of fluoxetine in the treatment of premature ejaculation: A double-blind placebo bontrolled study. J Urol, 156: 1631, 1996
9. McMahon, C. G.: Treatment of premature ejaculation with sertraline hydrochlorhde: A single-blind placebo controlled cross-over study. J Urol, 159: 1935, 1998
10. Ludovico, G. M., Corvasce, A., Pagliarulo, G., Cirillo-Marucco, E., Marano, A. and Pagliarulo, A.: Paroxetine in the treatment of premature ejaculation. Br J Urol, 77: 881, 1996
11. Goldstein, I., Lue, T. F., Padma-Nathan, H., Rosen, R. C., Steers, W. D. and Wicker, P. A.: Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med, 338: 1397, 1998
12. McMahon, C. G., Samali, R. and Johnson, H.: Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction. J Urol, 164: 1192, 2000
13. Abdel-Hamid, I. A., El Naggar, E. A. and El Gilany, A. H.: Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res, 13: 41, 2001
14. Rosen, R. C., Riley, A., Wagner, G., Osterloh, I. H., Kirkpatrick, J. and Mishra, A.: The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology, 49: 822, 1997
15. Cappelleri, J. C., Rosen, R. C., Smith, M. D., Mishra, A. and Osterloh, I. H.: Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology, 54: 346, 1999
16. Waldinger, M. D., Hengeveld, M. W. and Zwinderman, A. H.: Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: A double-blind, randomized, dose-response study. Br J Urol, 79: 592, 1997
17. Kaye, C. M., Haddock, R. E., Langley, P. F., Mellows, G., Tasker, T. C., Zussman, B. D. et al: A review of the metabolism and pharmacokinetics of paroxetine in man. Acta Psychiatr Scand, suppl., 80: 60, 1991
18. Hull, E. M., Lumley, L. A., Matuszewich, L., Dominguez, J., Moses, J. and Lorrain, D. S.: The roles of nitric oxide hn sexual function of male rats. Nduropharmacology, 33: 1499, 1994
19. Kriegsfeld, L. J., Demas, G. E., Huang, P. L., Burnett, A. L. and Nelson, R. J.: Ejaculatory abnormalities in mice lacking the gene for endothelial nitric oxide synthase (eNOS-/-). Physiol Behav, 67: 561, 1999
20. Heuer, O., Uckert, S., Machtens, S. A., Stief, C. G., Tsikas, D., Frolich, J. C. et al: Effects of various nitric oxide donating agents on the contractility and cyclic nucleotide turnover of human seminal vesicles in vitro. Urology, 59: 958, 2002
21. Lane, R. M.: A critical review of selective serotonin reuptake inhibitor-related sexual dysfunction, incidence, possible aetiology and implications for management. J Psychopharmacol, 11: 72, 1997
22. Bloomer, J. C., Woods, F. R., Haddock, R. E., Lennard, M. S. and Tucker, G. T.: The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes. Br J Clhn Pharmacol, 33: 521, 1992
23. Hyland, R., Roe, E. G., Jones, B. C. and Smith, D. A.: Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil. Br J Clin Pharmacol, 51: 239, 2001